期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重组活化Ⅶ因子对严重创伤合并创伤性凝血病预后的影响 被引量：5

Clinical and prognostic observation on severe trauma patients with traumatic coagulopathy by recombinant activated factor Ⅶ
下载PDF
导出
摘要 目的观察重组活化凝血因子Ⅶ对严重创伤合并创伤性凝血病患者外源性凝血功能、病死率和输血量的影响。方法收集50例严重创伤合并创伤性凝血病患者,分为二组,观察组共27例,在损害控制理念下均予静滴活化重组Ⅶ因子,对照组共23例,应用常规治疗的方法,观察相关指标的改变。结果观察组患者15 d死亡率明显低于对照组(14.81%vs 43.48%),观察组48 h内浓缩红细胞输注量(18.72±3.76 vs 23.52±6.70)、冰冻血浆输注量(19.32±4.30 vs 23.06±4.36)和评分(2.08±0.24 vs 4.41±1.14)均明显低于对照组。结论重组活化凝血因子Ⅶ能改善患者的外源性凝血功能,降低患者病死率,减少输血量。 Objective To investigate the effect of extrinsic coagulation function, mortality rate and blood transfusion on severe trauma patients with trauma coagulopathy by recombinant activated factor Ⅶ. Methods Fifty cases of severe trauma patients with traumatic coagulopathy were divided into two groups. The observation group （27 cases） were performed by recombinant activated factor Ⅶ, the control group （23 cases） were performed by conventional treatment. The related index changes were analyzed in the two groups. Results The motality rate of 15 days were lower in the observation group than in the control group（14.81% vs 43.48%）. The 48 h concentrated red cell transfusion amount（ 18.72±3.76 vs 23.52±6.70）, frozen plasma infusion （19.32±4.30 vs 23.06±4.36） and scores （2.08±0.24 vs 4.41±1.14） were lower in the observation group than in the control group. Conclusion Treatment of recombinant activated factor Ⅷ can improve the extrinsic coagulation function, reduce the mortality rate and blood volume.
作者 徐庆余 潘光华 郑旭东 武卫 胡永启
机构地区 浙江省瑞安市人民医院急救中心
出处 《中国现代医生》 2012年第31期46-48,共3页 China Modern Doctor
基金 浙江省瑞安市科技局资助项目(201002058)
关键词 创伤性凝血病 严重创伤 重组活化Ⅶ因子 Traumatic coagulopathy Severe trauma Recombinant activated factor VII
分类号 R641 [医药卫生—外科学]
  • 相关文献

参考文献21

  • 1R.Brohi K, Dutton RP,et al. The coagulopathy of trauma : a reviewof mechanisms[J]. J Trauma, 2008,65 (4) : 748-754.
  • 2徐少文,张茂.重视对创伤性凝血病的认识与防治[J].中华急诊医学杂志,2009,18(4):344-347. 被引量：30
  • 3Holcomb JB,Jenkins D, Rhee P,et al. Damage control resuscitation:directly addlressing the early coagulopathy of trauma[J]. J Trauma,2007,62?2):307-310.
  • 4Brohi K,Cohen Q[ ,Ganter MT,et al. Acute eoagulopathy of traumahypoperfusion induces systemic anticoagulation and hyperfibrinolysis [J].JTrauma,2008,64(5) :1211-1217.
  • 5Dutton RP, Conti BM. The role of recombinant activated factor VII inbleeding trauma patients[J]. Curt Opin Anaesthesiol, 2009,22 (2) : 299-304.
  • 6Boffard KD, Riou B, Warren B,et al. Recombinant factor W a asadjunctive therapy for bleeding control in severely injured traumapatients :two parallel randomized,placebo-controlled,doubleblind clinicaltrials[J]. J Trauma,2005,59( 1) :8-18.
  • 7Mayo A, Misgav M, Kluger Y,et al. Recombinant activated factor W(NovoSeven):addition to replacement therapy in acute,uncon -trolledand life-threatening bleeding[J]. Vox Sang, 2004,87 (1) : 34-40.
  • 8Brohi K,Singh J , Heron M , et al. Acute traumatic coagulopathy|J]. JTrauma,2003 ’ 54 (6); 1127-30.
  • 9Holcomb JB,Jenkins D,Rhee P,et al. Damage control resnscitation:directly addressing the early eoagulopathy of trauma [J]. J Trauma,2007,62(2):307-310.
  • 10Wafaisade A,Maegele M,Lefering R,et al. High plasma to red bloodcell ratios are associated with lower mortality rates in patientsreceiving multiple transfusion (4? red blood cell units <10) duringacute trauma resuscitation[J]. J Trauma,2011,70( 1) :81-89.

二级参考文献47

  • 1Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma [ J ]. J Trauma, 2007,62(2) :307-310.
  • 2Hoyt DB. Coagulopathy associated with trauma[ J]. J Trauma, 2008, 65 (4) : 747.
  • 3Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy[J]. J Traunm, 2003, 54(6): 1127-1130.
  • 4Niles SE, McLaughlin DF, Perkins JG, et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties[ J ]. J Trauma, 2008, 64(6): 1459-1463.
  • 5Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypopeffusion: modulated through the protein C pathway? [J]. Ann Surg, 2007, 245(5): 812-818.
  • 6Hoyt DB, Dutton RP, Hauser CJ, et al. Management of coagulopathy in the patients with multiple injuries: results from an international survey of clinical practice[J]. J Trauma, 2008, 65(4): 755-764.
  • 7Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms[J]. J Trauma, 2008, 65(4): 748-754.
  • 8Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect[J]. Curr Opin Crit Care, 2007, 13(6) : 680-685.
  • 9Kermode JC, Zheng Q, Milner EP. Marked temperature dependence of the platelet calcium signal induced by human yon WiUebrand factor[J]. Blood, 1999, 94(1 ) : 199-207.
  • 10Martini WZ, Dubick MA, Wade CE, et al. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs[J]. Crit Care Med, 2007, 35(6): 1568-1574.

共引文献85

同被引文献39

  • 1Letson HL,Pecheniuk NM,Mhango LP.Reversal of acute coagulopathy during hypotensive resuscitation using small-volume 7.5% NaC1 adenocaine and Mg2+ in the rat model of severe hemorrhagic shock[J].Critical care medicine,2012,40(8):4582-4583.
  • 2Howard B,Daley A,Cohen M.Prohemostatic interventions in Trauma:Resuscitation-associated coagulopathy,acute traumatic coagulopathy,hemostatic resuscitation,and other hemostatic interventions[J].Seminars in Thrombosis and Hemostasis,2012,38(3):557-559.
  • 3Cohen,MJ.Towards hemostatic resuscitation,the understanding of acute traumatic biology,changing massive bleeding,and damage-control resuscitation[J].The Surgical clinics of North America,2012,92(4):663-664.
  • 4Letson HL,Pecheniuk NM,Mhango LP.Reversal of acute coagulopathy during hypotensive resuscitation using small-volume 7.5% NaC1 adenocaine and Mg2 in the rat model of severe hemorrhagic shock[J].Critical care medicine,2012,40(8):996-997.
  • 5Mitra B,Cameron PA,Gruen RL.Aggressive fresh frozen plasmaFFP)with massive blood transfusion in the absence of acute traumatic coagulopathy[J].Injury,2012,43(1):1012-1013.
  • 6王同显,马保凤.重症创伤的凝血病及其处理[J].中国输血杂志,2007,20(5):440-442. 被引量：16
  • 7蔡蓓蓓,楼觉人,朱威.凝血因子Ⅶ的研究进展[C].全国血液制品学术交流会,2009:38-43.
  • 8Narayan RK,Maas AI,Marshall LF,et al.Recombinant factor Ⅶa in traumatic intracerebral hemorrhage:results of a dose-escalation clinical trial[J].Neurosurg,2008,62(4):776-786.
  • 9Mitra B,Cameron PA,Parr M J,et al.Recombinant factor Ⅶa in trauma patients with the triad of death[J].Injuy,2011,10 (1):1016-1021.
  • 10Kjalke M,Ezban M,Monroe DM,et al.High-dose factor Ⅶ a increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system[J].Br J Haematol,2001,114 (1):114-120.

引证文献5

二级引证文献4

中国现代医生
2012年 第31期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部